Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
13.88
-0.81 (-5.51%)
At close: Oct 23, 2026, 4:00 PM EDT
14.09
+0.21 (1.51%)
After-hours: Oct 23, 2026, 4:57 PM EDT
Biohaven Market Cap
Biohaven has a market cap or net worth of $2.1 billion as of October 23, 2026. It is the 6,153rd most valuable company in the world and the 1,693rd biggest in the United States. Its market cap has increased by 12.98% in one year.
Market Cap
2.10B
Enterprise Value
2.13B
1-Year Change
12.98%
Global Rank
Country Rank
#1,693 United States
Category
ChartMarket Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $2.10B, an increase of 701.48%. That is a compound annual growth rate of 66.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 1.77B | 18.47% |
| Dec 31, 2025 | 1.50B | -60.34% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aurinia Pharmaceuticals | 2.30B |
| Precigen | 2.28B |
| SELLAS Life Sciences Group | 2.26B |
| Celldex Therapeutics | 2.26B |
| Fortrea Holdings | 2.25B |
| Harmony Biosciences Holdings | 2.24B |
| Agios Pharmaceuticals | 2.23B |
| Vericel | 2.18B |